For release Thursday, March 25, 2021
Vancouver, BC – The Terry Fox Research Institute (TFRI) is pleased to announce the appointment of two key leadership personnel to develop, implement and manage the new Digital Health and Discovery Platform (DHDP) led by TFRI and its main partner Imagia.
The Digital Health and Discovery Platform (DHDP) is a pan-Canadian initiative focused on improving health outcomes for Canadians by deploying cutting-edge technologies to advance precision medicine. It is the first of its kind in Canada and is a scalable, discovery platform linking healthcare data with AI and other technologies to improve patient outcomes.
“We are pleased to have selected two amazing and extremely high-calibre people with track records for outstanding achievement for the roles of executive director and chief data officer for the DHDP. Bryce Pickard and Shari Dworkin, we look forward to working together on this exciting new pan-Canadian initiative to accelerate precision medicine,” remarked Dr. Victor Ling, TFRI’s president and scientific director.
“Bryce and Shari are passionate about the DHDP mission. They join us with well-established networks and strong expertise and will be instrumental in the overall success of the DHDP,” said Alexandre Le Bouthillier, CCO & Co-founder of Imagia.
“Joining the Terry Fox Research Institute and the Digital Health and Discovery Platform group is truly an honour. Combining contextual clinical data with the latest in data science technologies will accelerate medical breakthroughs, improve outcomes for patients, and deliver a more efficient and accessible healthcare system,” says Bryce Pickard, the new incoming executive director, based in London, Ontario.Read more about Bryce.
“I am proud to play a role in accelerating the use of trusted data in innovative and collaborative research and discovery leading to improvements in the health of Canadians,” says Shari Dworkin, who formerly worked for Ontario Health and Cancer Care Ontario and lives in Toronto. Read more about Shari.
Both began employment with TFRI in March. They will work with the DHDP’s Executive Committee and stakeholders. They will also serve on the Executive of the Terry Fox Research Institute and work with TFRI’s new Vancouver-based Chief Financial Officer Gordon Schwark, who joined TFRI in February. Read more about Gordon.
To learn more about the DHDP, visit www.dhdp.ca
About The Terry Fox Research Institute
The Terry Fox Research Institute (TFRI), established in 2007, invests in world-class, collaborative cancer research teams and partnerships. Together with its research and funding partners, TFRI is working to inspire the transformation of cancer research in this country by bringing together leading cancer research and treatment organizations in Canada and empowering them under the framework of the Marathon of Hope Cancer Centres Network. www.tfri.ca
Imagia, an AI healthcare company, develops digital medical innovations that improve the health of cancer patients and those afflicted with other high-burden diseases. Through its collaborative ecosystem, Imagia EVIDENSTM enables hospitals, medical device manufacturers, pharmaceutical companies, and diagnostic companies around the world to access and utilize healthcare data while preserving data privacy. The company’s head office is located in Montreal, Canada. imagia.com
For further information: For TFRI: Kelly Curwin, firstname.lastname@example.org
, cell:778-237-8158, office: 604-675-8223; For Imagia: Shelley Epstein, email@example.com